参考文献/References:
[1] Thurman DJ, Beghi E, Begley CE, et al. Standards for epide-
miologic studies and surveillance of epilepsy [J]. Epilepsia,
2011, 52 (Suppl 7): 2-26.
[2] Gao L, Xia L, Zhao FL, et al. Clinical efficacy and safety of
the newer antiepileptic drugs as adjunctive treatment in
adults with refractory partial-onset epilepsy: a meta-ana-
lysis of randomized placebo-controlled trials [J]. Epilepsy
Res, 2013, 103(1): 31-44.
[3] 姚 兰，孟红梅. 难治性癫痫的临床研究及治疗现状分析
[J]. 中华神经科杂志，2012，45（6）：434-435.
[4] Wu XY, Hong Z, Wu X, et al. Multicenter double-blind,
randomized, placebo-controlled trial of levetiracetam as
add-on therapy in Chinese patients with refractory partial-
onset seizures [J]. Epilepsia, 2009, 50(3): 398-405.
[5] Fang Y, Wu X, Xu L, et al. Randomized-controlled trials of
levetiracetam as an adjunctive therapy in epilepsy of multi-
ple seizure types [J]. Clin Neurosci, 2014, 21(1): 55-62.
[6] Xiao Z, Li JM, Wang XF, et al. Efficacy and safety of leve-
tiracetam (3,000 mg/day) as an adjunctive therapy in Chi-
nese patients with refractory partial seizures [J]. Eur Neurol,
2009, 61(4): 233-239.
[7] 段晓玲，肖 农. 从左乙拉西坦到Brivaracetam抗癫癎药
物的发展趋势[J]. 第二军医大学学报，2011，32（5）：550-
553.
[8] French JA, Costantini C, Brodsky A, et al. Adjunctive briva-
racetam for refractory partial-onset seizures: a randomized,
controlled trial [J]. Neurology, 2010, 75(6): 519-525.
[9] Van Paesschen W, Hirsch E, Johnson M, et al. Efficacy and
tolerability of adjunctive brivaracetam in adults with uncon-
trolled partial-onset seizures: a phase IIb, randomized,
controlled trial [J]. Epilepsia, 2013, 54(1): 89-97.
[10] Kwan P, Trinka E, Van Paesschen W, et al. Adjunctive bri-
varacetam for uncontrolled focal and generalized epilepsies:
results of a phase III, double-blind, randomized, placebo-
controlled, flexible-dose trial [J]. Epilepsia, 2014, 55(1):
38-46.
[11] Ryvlin P, Werhahn KJ, Blaszczyk B, et al. Adjunctive briva-
racetam in adults with uncontrolled focal epilepsy: results
from a double-blind, randomized, placebo-controlled trial
[J]. Epilepsia, 2014, 55(1): 47-56.
[12] Biton V, Berkovic SF, Abou-Khalil B, et al. Brivaracetam
as adjunctive treatment for uncontrolled partial epilepsy in
adults: a phase Ⅲ randomized, double-blind, placebo-
controlled trial [J]. Epilepsia, 2014, 55(1): 57-66.
[13] Baulac M, Brodie MJ, Patten A, et al. Efficacy and tolerabi-
lity of zonisamide versus controlled-release carbamazepine
for newly diagnosed partial epilepsy: a phase 3, randomised,
double-blind, non-inferiority trial [J]. Lancet Neurol, 2012,
11(7): 579-588.
[14] 周伯庭. SCN1A和GABA-A受体亚基基因多态性与卡马
西平抗癫痫疗效及药物安全性研究[D]. 中南大学，2012.
[15] Sackellares JC, Ramsay RE, Wilder BJ, et al. Randomized,
controlled clinical trial of zonisamide as adjunctive treat-
ment for refractory partial seizures [J]. Epilepsia, 2004,
45(6): 610-617.
[16] Lu Y, Xiao Z, Yu W, et al. Efficacy and safety of adjunctive
zonisamide in adult patients with refractory partial-onset
epilepsy: a randomized, double-blind, placebo-controlled
trial [J]. Clin Drug Investig, 2011, 31(4): 221-229.
[17] 李继川，陈春富，张 君，等. 观察普瑞巴林对因药物过度
使用而致头痛患者的疗效[J]. 中国临床药理学杂志，
2013，29（1）：9-11.
[18] Pulman J, Hemming K, Marson AG. Pregabalin add-on for
drug-resistant partial epilepsy [J]. Cochrane Database Syst
Rev, 2014, 12(3): CD005612.
[19] French J, Brandt C, Friedman D, et al. Adjunctive use of
controlled-release pregabalin in adults with treatment-
resistant partial seizures: a double-blind, randomized,
placebo-controlled trial [J]. Epilepsia, 2014, 55(8): 1220-
1228.
[20] Doty P, Hebert D, Mathy FX, et al. Development of lacosa-
mide for the treatment of partial-onset seizures [J]. Ann N Y
Acad Sci, 2013, 1291(7): 56-68.
[21] Chung S, Sperling MR, Biton V, et al. Lacosamide as ad-
junctive therapy for partial-onset seizures: a randomized
controlled trial [J]. Epilepsia, 2010, 51(6): 958-967.
[22] Paquette V, Culley C, Greanya ED, et al. Lacosamide as
adjunctive therapy in refractory epilepsy in adults: a sys-
tematic review [J]. Seizure, 2015, 25: 1-17.
[23] Ben-Menachem E, Gabbai AA, Hufnagel A, et al. Eslicar-
bazepine acetate as adjunctive therapy in adult patients with
partial epilepsy [J]. Epilepsy Res, 2010, 89(2-3): 278-285.
[24] Sperling MR, Abou-Khalil B, Harvey J, et al. Eslicarbaze-
pine acetate as adjunctive therapy in patients with uncon-
trolled partial-onset seizures: results of a phase Ⅲ, double-
blind, randomized, placebo-controlled trial [J]. Epilepsia,
2015, 56(2): 244-253.
[25] Krauss GL, Bar M, Biton V, et al. Tolerability and safety of
perampanel: two randomized dose-escalation studies [J].
Acta Neurol Scand, 2012, 125(1): 8-15.
[26] French JA, Krauss GL, Biton V, et al. Adjunctive peram-
panel for refractory partial-onset seizures: randomized
phase Ⅲ study 304 [J]. Neurology, 2012, 79(6): 589-596.
[27] French JA, Krauss GL, Steinhoff BJ, et al. Evaluation of
adjunctive perampanel in patients with refractory artial-
onset seizures: results of randomized global phase Ⅲ study
305 [J]. Epilepsia, 2013, 54(1): 117-125.
[28] Krauss GL, Serratosa JM, Villanueva V, et al. Randomized
phase Ⅲ study 306: adjunctive perampanel for refractory
partial-onset seizures [J]. Neurology, 2012, 78: 1408-1415.
[29] Hsu WW, Sing CW, He Y, et al. Systematic review and
meta-analysis of the efficacy and safety of perampanel in
the treatment of partial-onset epilepsy [J]. CNS Drugs,
2013, 27(10): 817-827.
[30] French JA, Abou-Khalil BW, Leroy RF, et al. Randomized,
double-blind, placebo-controlled trial of ezogabine
(retigabine) in partial epilepsy [J]. Neurology, 2011, 76(18):
1555-1563.
[31] Halford JJ, Ben-Menachem E, Kwan P, et al. A randomized,
double-blind,placebo-controlled study of the efficacy,
safety, and tolerability of adjunctive carisbamate treatment
in patients with partial-onset seizures [J]. Epilepsia, 2011,
52(4): 816-825.
[32] 孟曙庆，张 洪. 难治性癫痫的治疗进展[J]. 中华临床医
师杂志（电子版），2013，7（15）：7115-7119.
相似文献/References:
[1]郑 玺 顿晓熠.迷走神经刺激术对药物难治性癫痫患者认知功能的影响及其相关因素分析[J].中国临床神经外科杂志,2017,(03):142.[doi:10.13798/j.issn.1009-153X.2017.03.005]
ZHENG Xi,DUN Xiao-yi..Observation of cognitive function and analysis of factors related to it in patients with intractable epilepsy after treatment by vagus nerve stimulation[J].,2017,(03):142.[doi:10.13798/j.issn.1009-153X.2017.03.005]
[2]关宇光 于思科 刘长青 张 尧 陈思畅 丁浩然 周 健 栾国明.立体定向脑电图引导下射频热凝毁损术治疗药物难治性癫痫[J].中国临床神经外科杂志,2017,(06):369.[doi:10.13798/j.issn.1009-153X.2017.06.001]
GUAN Yu-guang,YU Si-ke,LIU Chang-qing,et al.Stereotatic EEG-guided radio-frequency thermocoagulation of epileptogenic zones in the patients with refractory epilepsy[J].,2017,(03):369.[doi:10.13798/j.issn.1009-153X.2017.06.001]
[3]杜秀玉 综述 栾国明 审校.大脑半球切除术后脑可塑性的研究进展[J].中国临床神经外科杂志,2017,(06):391.[doi:10.13798/j.issn.1009-153X.2017.06.008]
[4]陈俊喜 郭 强 谭红平 王艮波 华 刚.ROSA引导下立体定向脑电图在儿童难治性癫痫手术中作用[J].中国临床神经外科杂志,2017,(09):623.[doi:10.13798/j.issn.1009-153X.2017.09.005]
CHEN Jun-xi,GUO Qiang,TAN Hong-ping,et al.Application of ROSA-guided stereoelectroencephalography surgery for intractable epilepsy in children[J].,2017,(03):623.[doi:10.13798/j.issn.1009-153X.2017.09.005]
[5]王逸鹤 赵国光 单永治 樊晓彤 安 阳 卢 超.局灶性皮质发育不良致药物难治性癫痫的手术预后及其影响因素[J].中国临床神经外科杂志,2017,(11):737.[doi:10.13798/j.issn.1009-153X.2017.11.001]
WANG Yi-he ZHAO Guo-guang,SHAN Yong-zhi,FAN Xiao-tong,et al.Analysis of factors related to postoperative prognoses in focal cortical dysplasia patients with refractory epilepsy[J].,2017,(03):737.[doi:10.13798/j.issn.1009-153X.2017.11.001]
[6]徐德辉 谢海涛 伍犹梁 谢学敏 余佳彬 张晓静 隋立森 赵 敏.脑灰质异位合并巨脑回及海马硬化致药物难治性癫痫1例[J].中国临床神经外科杂志,2019,(01):64.[doi:10.13798/j.issn.1009-153X.2019.01.022]
[7]田海港 郭效东 王本瀚.迷走神经刺激术对药物难治性癫痫病人胃肠道功能的影响[J].中国临床神经外科杂志,2020,(02):103.[doi:10.13798/j.issn.1009-153X.2020.02.014]
[8]谭红平 郭 强 华 刚 陈俊喜 唐晓伟 陈淼彬 朱 丹.胚胎发育不良性神经上皮肿瘤继发癫痫的外科治疗[J].中国临床神经外科杂志,2021,26(01):8.[doi:10.13798/j.issn.1009-153X.2021.01.003]
TAN Hong-ping,GUO Qiang,HUA Gang,et al.Surgical treatment of patients with epilepsy due to dysembryoplastic neuroepithelial tumors[J].,2021,26(03):8.[doi:10.13798/j.issn.1009-153X.2021.01.003]
[9]韩彦明 沈云娟 史 哲 刘亚丽 杨宝慧 王天成 张新定.神经节细胞胶质瘤相关癫痫的外科治疗[J].中国临床神经外科杂志,2021,26(07):505.[doi:10.13798/j.issn.1009-153X.2021.07.003]
HAN Yan-ming,SHEN Yun-juan,SHI Zhe,et al.Surgical treatment for patients with ganglioglioma-related epilepsy[J].,2021,26(03):505.[doi:10.13798/j.issn.1009-153X.2021.07.003]
[10]陈思畅 单永治 赵国光.激光间质热疗在脑部疾病治疗中的应用现状[J].中国临床神经外科杂志,2021,26(08):637.[doi:10.13798/j.issn.1009-153X.2021.08.021]